OECD proposes new rules for multinational drug studies

02/27/2013 | PharmaTimes (U.K.)

The Organization for Economic Co-operation and Development has called on member nations to harmonize their rules for risk management of multinational clinical trials run by universities, hospitals and other nonprofit organizations. Such noncommercial drug trials increasingly involve study sites in multiple countries, and differing national regulations can raise barriers and costs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC